Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microfold cells, commonly known as M cells, are specialized epithelial cells located within the follicle-associated epithelium (FAE) of Peyer's patches and other mucosa-associated lymphoid tissues (MALT) (Mabbott et al., 2013, Nature Reviews Microbiology). Unlike typical enterocytes, M cells possess a unique morphology characterized by a lack of traditional microvilli and a specialized basal pocket that houses immune cells such as dendritic cells and B cells (Neutra et al., 1996, Annual Review of Immunology). Their central biological role is the sampling of lumenal antigens and pathogens, which they transport via transcytosis from the apical surface to the underlying lymphoid tissue to initiate a targeted mucosal immune response (Hase et al., 2009, Nature). While critical for immune surveillance, M cells are frequently exploited as entry portals by various pathogens, including Salmonella typhimurium, Shigella, and Prions, which can lead to systemic infection (Ohno et al., 2009, Nature). In the context of drug development, M cells represent a significant target for the oral delivery of vaccines and macromolecular therapeutics, as they provide a unique pathway to bypass the degradative environment of the intestinal lumen (Azizi et al., 2010, Journal of Controlled Release). Current research focuses on utilizing M-cell-specific surface markers, such as Glycoprotein 2 (GP2), to direct vaccine-loaded nanoparticles or ligand-conjugated antigens for efficient mucosal immunization (Kanaya et al., 2012, Polymer Journal).
M cells facilitate the transport of lumenal antigens, particulate matter, and pathogens across the epithelial barrier via apical-to-basal transcytosis for presentation to underlying dendritic cells and lymphocytes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microfold cell (M cell).